W. Warren

发表

A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

M. Stratton, G. Bignell, L. Aaltonen, 1998, Nature.

Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.

M. Stratton, B. Gusterson, C. Fisher, 1990, Oncogene.

Analysis of the p53 tumor‐suppressor gene in hepatocellular carcinomas from britain

C. Challen, J. Lunec, W. Warren, 1992, Hepatology.

Characterization of the translocation between chromosomes X and 18 in human synovial sarcomas.

C. Cooper, B. Gusterson, C. Fisher, 1989, Oncogene.

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

D. Clayton, D. Easton, S. Seal, 1995, Nature Genetics.

Somatic mutations of KIT in familial testicular germ cell tumours

Katherine M. Tucker, D. Easton, M. Stratton, 2004, British Journal of Cancer.

Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.

M. Stratton, R. Eeles, D. Easton, 1993, Oncogene.

Expression of p53 in premalignant and malignant squamous epithelium.

B. Gusterson, H. Jayatilake, D. Lane, 1991, Oncogene.

Increased expression and mutation of p53 in choroidal melanoma.

C. Cooper, W. Warren, K. Tobal, 1992, British Journal of Cancer.

Increased expression andmutation ofp53inchoroidal melanoma

C. Cooper, W. Warren, J. Hungerford, 1992 .

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

S. Seal, M. Stratton, N. Rahman, 1999, Journal of the National Cancer Institute.

No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.

B. Ponder, R. Eeles, D. Easton, 1992, Oncogene.

Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.

M. Stratton, S. Venitt, P. Biggs, 1995, Carcinogenesis.

A survey of homozygous deletions in human cancer genomes.

E. Birney, M. Stratton, P. Futreal, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Chemical induction of thymomas in AKR mice: Interaction of chemical carcinogens and endogenous murine leukemia viruses. Comparison of N‐methyl‐N‐nitrosourea and methyl methanesulphonate

C. Cooper, W. Warren, Jeremy Clark, 1990, Molecular carcinogenesis.

Activated Ki‐ras genes in bladder epithelial cell lines transformed by treatment of primary mouse bladder explant cultures with 7,12‐dimethylbenz[a]anthracene

C. Cooper, I. Summerhayes, W. Warren, 1988, Molecular carcinogenesis.

Screening for ESR mutations in breast and ovarian cancer patients

A. Børresen-Dale, M. Stratton, R. Wooster, 1997, Human mutation.

Identification of the familial cylindromatosis tumour-suppressor gene

A. Ashworth, S. Seal, M. Stratton, 2000, Nature Genetics.

Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.

S. Seal, M. Stratton, G. Bignell, 1998, Cancer research.

Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer.

M. Stratton, S. Venitt, P. Biggs, 1993, Mutagenesis.

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

Nazneen, Stratton, S. Seal, 1999, Journal of the National Cancer Institute.

Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12–q13

S. Seal, M. Stratton, R. Siebert, 2000, Human Genetics.

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

M. Skolnick, F. Couch, S. Ingles, 1995, JAMA.

The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.

D. Smedley, C. Cooper, J. Clark, 1998, Human molecular genetics.

Screening for ESR mutations in breast and ovarian cancer patients

A. Børresen-Dale, M. Stratton, R. Wooster, 1997, Human mutation.